Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 15,625-15,636 of 23,847
Behavioral study icon
Active Not RecruitingNCT06266390

Individualized (fMRI-guided) TMS Treatment for Depression

This study is looking at whether questionnaires and follow-up can help people with Depression or Persistent depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Philadelphia
DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Behavioral study icon
CompletedNCT06142786

Individualized Alpha Neurofeedback for ADHD

This study is comparing Enhancing the individualized upper alpha frequency band and suppressing the lower alpha band with Sham neurofeedback for people with Adhd. Participants receive Enhancing the individualized upper alpha frequency band and suppressing the lower alpha band or Sham neurofeedback and complete study visits and assessments.

In Hong Kong
ADHDBehavioralFrom 5 Years to 13 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
ADHD
Behavioral study icon
CompletedNCT05680727

Individualized Functional Connectivity Targeting in aiTBS for Depression

This study is looking at whether transcranial magnetic stimulation can help people with major depression, Depression, or Mental Disorder. Participants take part in transcranial magnetic stimulation and complete follow-up assessments.

In Boston
DepressionBehavioralFrom 22 Years to 80 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Depression
Device study icon
Active Not RecruitingNCT05829681

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Stanford
OCDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
OCD
Behavioral study icon
CompletedNCT05537285

Individualized Neuromodulation for Anhedonic Depression

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In San Diego
DepressionBehavioralFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Device study icon
Active Not RecruitingNCT06874374

Individualized Non-invasive Brain Stimulation for Major Depressive Disorder

This observational study is following people with Depression - depression or Transcranial Alternating Current Stimulation to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Chapel Hill
DepressionDeviceFrom 18 Years to 70 Years
Countries
United States
Sponsor
Pulvinar Neuro, LLC
Condition
Depression
Device study icon
CompletedNCT03515408

Individualized Precise Localization of rTMS on Precentral and Parietal Gyrus

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In Hangzhou
ADHDDeviceFrom 19 Years to 30 Years
Countries
China
Sponsor
Hangzhou Normal University
Condition
ADHD
Device study icon
TerminatedNCT05319080

Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In New York
SchizophreniaDeviceFrom 22 Years to 55 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.